KeyBank National Association
CABA icon

KeyBank National Association’s Cabaletta Bio CABA Stock Holding History

KeyBank National Association’s Portfolio CABA Stock Details CABA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$121K Buy
+39,005
New +$128K ﹤0.01% 1298
2024
Q4 		– Sell
-21,506
Closed -$102K – 1159
2024
Q3 		$102K Hold
21,506
– – ﹤0.01% 1120
2024
Q2 		$161K Buy
21,506
+5,612
+35% +$68.8K ﹤0.01% 1067
2024
Q1 		$271K Buy
+15,894
New +$341K ﹤0.01% 959

Other funds holding CABA

Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Woodline Partners
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

KeyBank National Association's CABA Position: Q2 2026 in Review

KeyBank National Association opened a new position in Cabaletta Bio (CABA) in Q2 2026: 39,005 shares worth $121K. The stake represents ﹤0.01% of the portfolio and ranks #1298 among its holdings. This is a return to the name: KeyBank National Association previously reported a position in CABA as recently as Q3 2024.

KeyBank National Association first reported a position in CABA in Q1 2024 and has held it in 4 quarters since. The position peaked at $271K in Q1 2024. 139 funds tracked by Wall St. Rank hold CABA as of Q2 2026.

  • KeyBank National Association held 39,005 shares of Cabaletta Bio worth $121K as of Q2 2026.
  • Cabaletta Bio was a new KeyBank National Association position in Q2 2026.
  • Cabaletta Bio made up ﹤0.01% of KeyBank National Association's portfolio in Q2 2026, its #1298 holding.
  • KeyBank National Association first reported a position in Cabaletta Bio in Q1 2024 and has held it in 4 quarters since.
  • KeyBank National Association's Cabaletta Bio position peaked at $271K in Q1 2024.
  • 139 funds tracked by Wall St. Rank held Cabaletta Bio as of Q2 2026.

Based on KeyBank National Association's 13F filing for Q2 2026, filed 28 Jul 2026.